"I think it goes without saying that being current on financial filings is first on anyone's list of wishes for this stock."
But if you were directing your response to new investors, it absolutely doesn't go without saying. It's the first thing that one should be saying and, while I don't know where your post went, I distinctly remember you not saying it.
I also felt, since you were directing new investors to my link to Reuters, that I should make it clear that I was providing the link as a service but had strong feelings about the quality of the information provided and that I did not endorse the report in any way.
Finally, we just plain disagree on the value to new investors of an education in short selling in terms of its relevance to SPNG.
My purpose was not to argue with you.....or anyone else. I don't think in terms of naysayers/pumpers/bashers, etc. My purpose was and always is to express my own point of view on the issue presented.
Focusing on the product is a fine choice of priorities......I admit to having never used Spongetech's. I hold about 10 mostly large cap stocks and I suspect that the same thing could be said of 6 or 7 of those, so I don't share that priority. I think the ability to multiply is more important. And a knowledge of the product's market. And it's just my baseless opinion that when someone in a directly competing business said "Impossible, categorically not" in response to "the idea that a company that sells sponges with soap in them can generate $50 million in annual revenue" that he both meant and said those words in spite of their recantation. Maybe he had a motive and maybe he didn't, but he sure should have a better feel for such things than you or I. The bottom line of this is, while reports from the field indicate that there is soap in the sponge, there is no reliable source of information showing the multiplication of the number of sponges actually shipped times its wholesale price and deducting therefrom the cost of producing, advertising and selling them and administrating the process. Which I must admit I find to be more critical concerns for investment purposes than their soapiness and the retention thereof.......although without that there's admittedly no product at all. So, it's my personal feeling that you may be right when you say "knowing the products seems to be the most valuable research a person could do today given the lack of the financial filings" and that that fact alone should give new investors a great cause for concern.
Please don't mistake this for an argument.......we just have a different set of priorities. I wish you luck and by all means do it your way.
AI
